md-medicaldata

Authors

 

Milena Todorović¹, Zdenka Gojković², Marin Kvaternik¹, Ljiljana Stanivuk¹

JZU Institut za javno zdravstvo Republike Srpske¹ / Public Health Institute of the Republic of Srpska, Regional centre Doboj¹
Univerzitetski klinički centar Republike Srpske, Banjaluka² / University Clinical Centre of the Republic of Srpska, Banjaluka²

 

The paper was received on 06.01.2017. / Accepted on 18.01.2017.

 

Correspondence to

Milena Todorović,
Ul.Kneza Lazara 11B/23,74000 Doboj,
Republika Srpska, Bosna i Hercegovina
Telefon: +387 65 684 810
e-mail: tmilena64@gmail.com

 

 

Abstract

 

Introduction: Obesity is a disease characterized by excessive body fat mass to an extent that leads to poor health and a series of complications. The aim was to examine the impact of medical nutrition therapy on obesity, particularly the impact on the abdominal obesity, as well as glycaemia and triglycerides in obese people who have been on medical nutrition therapy for six months. Materials and Methods: The study was conducted as a prospective study on a sample of 84 obese people, of both sexes, aged 40-60 years. Subjects were divided into two groups: the first group (respondents to the medical nutritional therapy -MNT) and second group (control group, patients without medical nutrition therapy). T-test was used to check the statistical significance. Results: The average reduction of obesity level of 5.6 kg / m2 in the first group proved to be statistically significant (t = 13.225, p = 0.000), with an average reduction in waist circumference of 10.15 cm, which is statistically significant (t = 13.932, p = 0.000). In the first group of respondents it has been noted that it is important to regulate blood glucose levels (t = 3.879, p = 0.000). Average reduction in triglycerides from 0.2 mmol/L in the first group, and increase in serum triglycerides by 0.03 mmol/L in the second group, did not prove to be statistically significant.
Discussion with the conclusion: By using medical nutrition therapy the degree of obesity decreased, especially abdominal obesity, which had an indirect positive effect on the regulation of blood glucose values, but it did not influence the decrease of serum triglycerides, as numerous similar studies had confirmed.

 

Key words

Medical Nutrition Therapy, glycaemia, obesity

 

 

Sažetak

 

Uvod: Gojaznost je oboljenje koje se karakteriše uvećanjem masne mase tijela u mjeri koja dovodi do narušavanja zdravlja i razvoja niza komplikacija. Cilj je ispitati uticaj medicinske nutritivne terapije na gojaznost i to, posebno na abdominalnu gojaznost, kao i na glikemiju i trigliceride kod gojaznih osoba koje su bile na medicinskoj nutritivnoj terapiji tokom šest mjeseci. Materijal i metode: Ispitivanje je sprovedeno kao prospektivna studija na uzorku od 84 gojazne osobe, oba pola, starosti 40-60 godina. Ispitanici su podijeljeni u u dvije grupe: prva grupa (ispitanici na medicinskoj nutritivnoj terapiji -MNT) i druga (kontrolna, ispitanici bez medicinske nutritivne terapije). Za provjeru statističke značajnosti korišćen je t-test. Rezultati: Prosječno smanjenje stepena gojaznosti od 5,6 kg/m2 u prvoj grupi pokazalo se statistički značajno (t=13,225, p=0,000), sa prosječnim smanjenjem obima struka od 10,15 cm što je statistički značajno (t=13,932; p=0,000). Kod prve grupe ispitanika zapaženo je i značajno regulisanje vrijednosti glukoze u krvi (t=3,879, p=0,000). Prosječno smanjenje vrijednosti triglicerida od 0,2 mmol/L u prvoj grupi, kao i porast serumskih triglicerida od 0,03 mmol/L u drugoj grupi nije se pokazalo kao statistički značajno. Diskusija sa zaključkom: Primjenom medicinske nutritivne terapije došlo je do smanjenja stepena gojaznosti, posebno abdominalne gojaznosti, a što je imalo posredno pozitivno djelovanje na regulisanje vrijednosti glikemije, dok nije uticalo na smanjenje vrijednosti triglicerida u serumu, što je brojnim sličnim studijama i potvrđeno.   

 

 

Ključne riječi:

Medicinska nutritivna terapija, glikemija, gojaznost

 

 

References

 

1. Houston M. The Role of Nutraceutical Supplements in the Treatment of Dyslipidemia. The journal of Clinical Hypertension. 2012; 14:121-132.
2.  Karapetrovic M, Acimovic Z, editors. Dyslipedemia: Causes, Diagnosis and Tretmant. New York: Nova Science Publishers; 2012.
3. Mertens I.L, Van Gaal L.F. Overweight, Obesity, and Blood Pressure: The Effects of Modest Weight Reduction. In: Obesity Research. 2000; 8:270-278.
4.  Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G., et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007; 25(9):1751–62.
5.  Srikanth S. Deedwania P. Management of Dyslipidaemia in Patients with Hypertension, Diabetes and Metabolic Syndrome. Current hypertension reports.2016;18 (10):76.
6.  Smolin M, Grosvenor L.A. Nutrition: science and applications. 1st ed. New Jersey: John Wiley & Sons; 2007.
7.  U.S. Department of Health and Human Servicea. Your Guide to Lowering Your Blood Pressure With DASH. NIH Publication No.06-4082, Originally Printed 1998, Revised 2006.
8.  Frank M. Sacks, Laura P. Svetkey, William M. Vollmer, Lawrence J. Appel, George A. Bray, David Harsha, et al. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet. The N Engl J Med. 2001;344 (1):3-10
9.  Mozaffarian D, Fahimi S, Gitanjali M. S, et al. Global Sodium Consumption and Death from Cardiovascular Causes. N Engl J Med 2014; 371:624-634
10. Siero M. Jose L. Chowdhury S. Ashor A. Oggioni C. Mathers C.J. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. British Journal of Nutrition. 2015; 113(1): 1-15.
11.  Bowman B.A, Russell R.M. Present knowledge in nutrition. 9th ed. Washington: International Life Sciences Institute; 2006.
12.  WHO. Protein and amino acid requirements in human nutrition. report of joint. Geneva: FAO/WHO/UNU; 2007.
13. Zhang P. Peterson M.  Su L.G. Wang C. S. Visceral adiposity is negatively associated with bone density and muscle attenuation. Am J Clin Nutr. 2015; 101:337-343.
14. Laura M, Maximilian W and Amanda J.K. Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome. Nutrients. 2015; 7:9416-9439.
15. Lee H.H. Lee H.J. Cho J.I. Stampfer M.J. Willett W.C. Kim C.I. Cho E. Overall and abdominal adiposity and hypertriglyceridemia among Korean adults: the Korean National Health and Nutrition Examination Survey 2007-2008. EJCN 2013;67: 83-90.
16. Kang J.Y. Wang W.H. Cheon Y.S. Lee J.H. Hwang M.K. Yoon S.H. Associations of Obesity and Dyslipidemia with Intake of Sodium, Fat, and Sugar among Koreans: a Qualitative Systematic Review. Clin Nutr Res.2016; 5(4):209-304.
17. Wei C. Lin Y. Yang Q. Li X. Yang J. Wang J. The Effect of Pratein-Euriched Meal Replacement on Waist Circumference Reduction among Overweight and Obese Chinese with Hyperlipidemia. J Am Coll Nutr.2016; 35(3):236-244.

UDK: 613.24
615.874
COBISS.SR-ID 230565644

PDF Todorović M. et al. • MD-Medical Data 2017;9(1): 023-026